1. India Stocks

  2. •

    Financial Services

  3. •

    Financial - Conglomerates
Arunjyoti Bio Ventures Limited

Arunjyoti Bio Ventures Limited

ABVL.BO
Arunjyoti Bio Ventures LimitedIN flagBombay Stock Exchange
5.86
INR
+0.31
- -
1.09BMarket Cap

Total Valuation

Arunjyoti Bio Ventures Limited carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at 1.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.09B
Enterprise Value1.46B

Valuation Ratios

Arunjyoti Bio Ventures Limited trades at a trailing price-to-earnings ratio of 1,060.45.

PE Ratio1,060.45
PS Ratio5.67
PB RatioN/A
P/TBV RatioN/A
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Arunjyoti Bio Ventures Limited trades at an EV/EBITDA multiple of 63.19 and an EV/FCF ratio of 206.90. The EV/Sales ratio of 5.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 63.19 provides insight into valuation relative to core operating earnings.

EV / Sales5.67
EV / EBITDA63.19
EV / EBIT63.19
EV / FCF206.90

Financial Position

Arunjyoti Bio Ventures Limited maintains a current ratio of 3.86, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 152.19, indicating elevated leverage, while an interest coverage ratio of 1.03 demonstrates limited ability to service its debt obligations.

Current Ratio3.86
Quick Ratio0.12
Debt / Equity152.19
Debt / EBITDAN/A
Interest Coverage1.03

Taxes

Over the trailing twelve months, Arunjyoti Bio Ventures Limited has paid 9.26M in income taxes, reflecting an effective tax rate of 771.11.

Income Tax9.26M
Effective Tax Rate771.11

Stock Price Statistics

Arunjyoti Bio Ventures Limited's stock has declined approximately -4.56026% over the past 52 weeks. The 50-day moving average sits at 5.95, while the 200-day moving average is 8.09.

Beta (5Y)N/A
52-Week Price Change-4.56026%
50-Day Moving Average5.95
200-Day Moving Average8.09
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Arunjyoti Bio Ventures Limited generated 257.98M in revenue and converted that into -8.04M in net income, yielding earnings per share of -0.05. EBITDA reached 23.16M, while operating income came in at 23.16M.

Revenue257.98M
Gross Profit250.25M
Operating Income23.16M
Pretax Income1.20M
Net Income-8.04M
EBITDA23.16M
EBIT23.16M
Earnings Per Share (EPS)-0.05

Margins

Arunjyoti Bio Ventures Limited operates with a gross margin of 97.00, reflecting its pricing power and cost economics. The operating margin of 8.98 and net profit margin of -3.12 provide insight into operational efficiency.

Gross Margin97.00
Operating Margin8.98
Pretax Margin0.47
Profit Margin-3.12
EBITDA Margin8.98

Scores

Arunjyoti Bio Ventures Limited posts an Altman Z-Score of 5.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.43